562 Benefit from atezolizumab in patients with a poor prognostic ovarian cancer in first-line setting: IMAGYN-050 trial
Benoit You,Charles Anderson,Sabrina Chiara Cecere, Aurore Carrot, Tashanna Myers,Florian Heitz, Sharma Sudarshan,Fatih Selçukbiricik,Carol Aghajanian, Josefin Fernebro,Stephanie Blank, Maria Elena Laudani,Premal Thaker,Mayu Yunokawa, Lynday willmott, Yvette He, Charles Landen, Yvonne G Lin, Jesús alarcón,Kathleen N Moore Oral Sessions（2024）
AI 理解论文
溯源树
样例
